2025-09-19_Biomedicines Webinar-2025-Banner.jpg){kind=logo}
Biomedicines Webinar | Extracellular Vesicles in Health and Disease
Postponed Notification
We regret to inform you that due to unforeseen circumstances, the webinar scheduled for 23 October has been postponed to 30 October at 13:00 CET.
If you have previously registered, there is no need to register again as your registration link remains unchanged. Should you have any questions or concerns, please feel free to contact us.
the chair
18th Biomedicines Webinar
Extracellular Vesicles in Health and Disease
Extracellular vesicles are nano particles secreted virtually from all cell types across all organisms. They contain thousands of molecules, that upon secretion and engulfment in recipient bystander cells, affect the phenotype of the recipient cells. Recently the scientific interest in these vesicles is increasing due to their potential use in medicine and agriculture.
In this webinar, we will present several examples of interesting studies conducted in Israel on the topic of extravesicles.
Date: 30 October 2025
Time: 13:00 pm CET | 20:00 pm CST Asia
Webinar ID: 871 5071 1183
Webinar Secretariat: journal.webinar@mdpi.com
Meet the Event Chair
Meet Our Speakers
Dr. Orit Uziel
1. The Felsenstein Medical Research Center, Rabin Medical Center; 2. Gray Faculty of Medical Sciences, Tel-Aviv University;
Dr. Uziel is the Head of the Research Group, "Telomeres and Exosomal Research", in Felsenstein Medical Research Center. Her current research focuses on the use of exosomes in various malignancies as a diagnostic marker and deciphering the roles of exosomes in providing a survival advantage to cancer cells.
Dr. Avraham Dayan
Life Sciences Core Facilities, Weizmann Institute of Science;
Dr. Dayan is a senior scientist and entrepreneur specializing in biotechnology, nanotechnology, and medical applications. He is the Head of the Multidisciplinary Vesicle Program at the Weizmann Institute of Science, where he leads cutting-edge EV and nanoparticle research infrastructures. At the same time, he serves as a director in multiple start-up companies.
Dr. Dayan holds a PhD in Molecular Microbiology and Biotechnology from Tel Aviv University and a postdoctoral fellowship in Molecular Genetics and Biochemistry. He has authored numerous high-impact publications and patents and is a frequently invited speaker at international conferences. His multidisciplinary expertise spans flow cytometry, nanomaterials, molecular delivery systems, and translational biomedical innovation.
Prof. Dr. Daniella Levy Erez
Institute of Nephrology, Schneider Children’s Medical Center of Israel and Felsenstein Research Institute, Tel Aviv University;
Daniella Levy Erez, MD, MTR is a Physician Scientist specializing in kidney disease and transplantation in children. Dr. Levy Erez completed her medical degree at Ben-Gurion University, her residency at Schneider Children’s Medical Center in Israel, and her pediatric nephrology fellowship at Children’s hospital of Philadelphia. Dr Levy Erez divides her time between clinical care at SCMCI as a senior pediatric nephrologist and in the transplantation lab in Felsentein research Center. Dr. Levy Erez main research focus is on identifying novel biomarkers for early detection of allograft rejection following kidney transplantation. Dr Levy Erez actively publishes in medical journals and has presented her work at international conferences and is part of European and American research consortiums and guidelines committees. Dr. Levy Erez is committed to advancing pediatric nephrology through clinical excellence and collaborative research initiatives as well as training the next generation of pediatric nephrologists. Dr. Levy Erez serves as a faculty member at Tel Aviv University as well as an adjunct faculty member in the Division of Nephrology at the Children’s Hospital of Philadelphia, where she actively participates in research. Dr Levy Erez vision is to improve pediatric patient care through translational research to benefit children with kidney disease.
Sponsors and Partners
Organizer
The webinar was hosted via Zoom and required registration to attend. The full recording can be found below. In order to learn about future webinars, you can sign up to our newsletter by clicking “Subscribe” at the top of the page.
The webinar focused on different aspects of extracellular vesicles (EVs) research. Three participants: Dr. Orit Uziel, Dr. Daniella Levi and Dr. Avraham Dayan described their studies spanning on various aspects of EVs research. Daniella described how her laboratory studied blood samples from patients undergoing kidney transplants in an attempt to identify certain proteins that will serve as markers for transplant rejection, and indeed they were able to preliminarily identify several. Avraham Dayan explained how he established a research center for EVs research at the Weizmann Institute of Science in Israel, where they provide researches with a whole package of EVs research. Orit Uziel described studies regarding EVs in hematological malignancies, that can function both as markers and as mediators of disease progression.
The Role of Telomere and Telomerase in Human Disease—2nd Edition
Edited by: Dr. Orit Uziel
Deadline for manuscript submissions: 31 December 2025
Extracellular Vesicles for Diagnosis and Treatment of Human Diseases
Edited by: Dr. Zoran Minic
Deadline for manuscript submissions: 30 November 2025